Multiplicom introduces genetic analysis of FAP genes using its MASTR technology

To identify at-risk individuals for familial adenomatous polyposis colon cancer (FAP), mutation analysis of the APC and MUYTH genes may be performed.
The new FAP MASTR assay targets the full coding exons of the APC and MUYTH genes covering 52 amplicons in total in only 3 PCR multiplexes.

With carefully developed PCR multiplexes and a fixed mixing scheme the amplicon normalization step is readily achieved and your sample-throughput per run can be maximized.
MASTR assays are compatible with the Roche Genome Sequencer systems as well as with the short read sequencing technologies such as Illumina, SOLiD and  Ion Torrent.

In the autumn of 2011, Multiplicom will introduce its HNPCC (Lynch syndrome) MASTR assay kit which is presently in final evaluation. Both FAP and HNPCC will have parallel processing steps.

Multiplicom continuously strives to expand its range of products and aims to provide a range of standardized MASTR assays for your diagnostics on next-gen sequencing.